New Dawn Bio
New Dawn Bio is a biotechnology company that develops cultured wood by growing plant stem cells in bioreactors to provide a sustainable alternative to traditional timber harvesting. Their technology aims to reduce deforestation by producing customizable, high-quality wood materials directly from cells without cutting trees.
verified 17 July 2026
↗ New Dawn Bio makes a piece of wood in the lab | WUR↗ Harnessing Nature's Signals for Custom-Grown Wood↗ New Dawn Bio 2026 Company Profile↗ New Dawn Bio - 2026 Company Profile, Team, Funding & Competitors - TracxnFact sheet
- HQ: Wageningen, Netherlands↗ New Dawn Bio makes a piece of wood in the lab | WUR↗ Harnessing Nature's Signals for Custom-Grown Wood↗ New Dawn Bio 2026 Company Profile↗ New Dawn Bio 🌳↗ New Dawn Bio | VentureRadar↗ New Dawn Bio - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- Founded in 2023↗ New Dawn Bio makes a piece of wood in the lab | WUR↗ Harnessing Nature's Signals for Custom-Grown Wood↗ New Dawn Bio 2026 Company Profile↗ New Dawn Bio 🌳↗ New Dawn Bio | VentureRadar↗ New Dawn Bio - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- Key technology: Plant cell-cultured wood production↗ New Dawn Bio makes a piece of wood in the lab | WUR↗ Harnessing Nature's Signals for Custom-Grown Wood↗ New Dawn Bio 2026 Company Profile↗ New Dawn Bio 🌳↗ New Dawn Bio | VentureRadar↗ New Dawn Bio - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- Founders: Tom Clement, Kianti Figler↗ New Dawn Bio makes a piece of wood in the lab | WUR↗ Harnessing Nature's Signals for Custom-Grown Wood↗ New Dawn Bio 2026 Company Profile↗ New Dawn Bio 🌳↗ New Dawn Bio | VentureRadar↗ New Dawn Bio - 2026 Company Profile, Team, Funding & Competitors - Tracxn
Recent developments
Norrsken Evolve has opened an Amsterdam hub following a €62M fund close, and has already deployed capital into New Dawn Bio as one of its Dutch portfolio companies. The N24 article also describes New Dawn Bio as 'Amsterdam-based', potentially indicating a location discrepancy with the current HQ listing of Wageningen.
Read more ↗tech.eu15 JulNorrsken Evolve has been confirmed as New Dawn Bio's first institutional investor, and it was Norrsken that introduced the company to CapitalT — which subsequently led the oversubscribed pre-seed round — after both were tenants at Norrsken House Amsterdam.
Read more ↗eu-startups.com15 Jul